Clinical Trial Update: 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19

View source ↗

Summary

A completed clinical trial evaluating Ga-68 FAPI PET/CT imaging to detect ongoing fibroblast activity in individuals recovering from COVID-19. The study include…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome
• Pulmonary Fibrosis

Drugs mentioned

• Ga-68-FAPI PET/CT tracer (Gallium-68 labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Post-Acute COVID-19, Post-Acute COVID-19 Infection | Status: COMPLETED